53 pages; Pharmaceutical Research and Manufacturers of America v. Walsh, No. 01–188 (May 19, 2003). From syllabus: 'The purpose of the 'Maine Rx' Program is to reduce prescription drug prices for state residents. Under the program, Maine will attempt to negotiate rebates with drug manufacturers.... [A]n association of nonresident drug manufacturers challenged the program before its commencement date, claiming that it is pre-empted by the Medicaid Act and violates the negative Commerce Clause.  MORE >>